Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of of VSA012 in Subjects with Paroxysmal Nocturnal Hemoglobinuria(PNH)

View source ↗

Summary

This is an early-phase clinical trial update evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of VSA012 in subj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• VSA012

Snippet

Sponsor: Visirna Therapeutics HK Limited | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Status: NOT_YET_RECRUITING